Michael James Birrer MD Ph.D.
Professor, Department of Medicine Harvard Medical School Director Gynecologic Medical Oncology
Join to view full profile
UAMS Medical Center449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Second FloorLittle Rock, AR 72205
Phone+1 501-686-8522
Dr. Birrer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1982 - 1985
Albert Einstein College of MedicineClass of 1982
Certifications & Licensure
VA State Medical License 1900 - Present
AR State Medical License 2019 - 2027
AL State Medical License 2017 - 2019
MA State Medical License 1984 - 2019
MD State Medical License 1985 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016
Clinical Trials
- Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer Start of enrollment: 2010 Apr 14
Publications & Presentations
PubMed
- Detection of mutant cancer-derived circRNAs in extracellular vesicles by rolling circle amplification.Mikołaj Piotr Zaborowski, Charles Pin-Kuang Lai, Alessandro Sammarco, Bence György, Xuan Zhang
Molecular Therapy. Nucleic Acids. 2026-09-08 - TGF-β Is Critical for Ovarian Cancer Migration, Invasion, and Chemosensitivity.Christopher Elms, Wei Wei, Michael J Birrer
Cancers. 2026-07-15 - Quality-of-life outcomes in newly diagnosed advanced cancer: subgroup analysis - a case for individual differences.Mei Bai, David Cella, Sangchoon Jeon, Rang Govindarajan, Michael J Birrer
BMJ Supportive & Palliative Care. 2026-02-18
Journal Articles
- Phase Ib Study of Mirvetuximab Soravtansine, a Folate Receptor Alpha (FRα)-Targeting Antibody-Drug Conjugate (ADC), in Combination with Bevacizumab in Patients with Pl...David M O'Malley, Ursula A Matulonis, Michael J Birrer, Cesar M Castro, Lainie P Martin, Gynecologic Oncology
- Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
- Primordial Germ Cells as a Potential Shared Cell of Origin for Mucinous Cystic Neoplasms of the Pancreas and Mucinous Ovarian TumorsLeona A Doyle, Daniel W Cramer, Michael Goggins, Ronny Drapkin, Jason L Hornick, Kevin M Elias, Michael Birrer, Michelle S Hirsch, The Journal of Pathology
Other
- Consensus on Molecular Subtypes of High-Grade Serous Ovarian CarcinomaMichael Birrer, MD, Clinical Cancer Research
https://www.doximity.com/articles/2d76bb27-90e6-4215-9c57-05d1d5652246
UpToDate, Wolters Kluwer Health - 2012-12-20 - Consensus on Molecular Subtypes of High-Grade Serous Ovarian CarcinomaMichael Birrer, MD, Clinical Cancer Research
https://www.doximity.com/articles/2d76bb27-90e6-4215-9c57-05d1d5652246
UpToDate, Wolters Kluwer Health - 2013-02-25
Press Mentions
UAMS Purchases Proton Center of Arkansas Securing Long-Term Advanced Cancer TreatmentJuly 30th, 2026- UAMS Receives $3.5 Million From CDC to Improve Colorectal Cancer ScreeningJanuary 21st, 2026
- UAMS Receives $1.5 Million NCI Grant to Train Next Generation of Cancer InnovatorsNovember 24th, 2025
Grant Support
- Novel Biomarkers In Ovarian CancerNational Cancer Institute2010–2012
- Proteomic, Genetic &Longitudinal Pathways To Ovarian Cancer Biomarker DiscoveryNational Cancer Institute2010–2011
- Genomic Stratification Of Ovarian Cancer PatientsNational Cancer Institute2010
- The Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisDivision Of Clinical Sciences - Nci2009
- The Molecular Genetics Of Gynecologic CancersDivision Of Clinical Sciences - Nci2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: